- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Oncology (Anti-cancer Drugs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Oncology (Anti-cancer Drugs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chemotherapy accounting for % of the Oncology (Anti-cancer Drugs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Blood Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oncology (Anti-cancer Drugs) include Roche, Novartis, Celgene, Amgen, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology (Anti-cancer Drugs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Others
Market segment by Application can be divided into
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
The key market players for global Oncology (Anti-cancer Drugs) market are listed below:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology (Anti-cancer Drugs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology (Anti-cancer Drugs), with price, sales, revenue and global market share of Oncology (Anti-cancer Drugs) from 2019 to 2022.
Chapter 3, the Oncology (Anti-cancer Drugs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology (Anti-cancer Drugs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oncology (Anti-cancer Drugs) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology (Anti-cancer Drugs).
Chapter 13, 14, and 15, to describe Oncology (Anti-cancer Drugs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Oncology (Anti-cancer Drugs) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology (Anti-cancer Drugs) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Blood Cancer
1.2.3 Breast Cancer
1.2.4 Gastrointestinal Cancer
1.2.5 Prostate Cancer
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology (Anti-cancer Drugs) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy (Biologic Therapy)
1.3.5 Hormonal Therapy
1.3.6 Others
1.4 Global Oncology (Anti-cancer Drugs) Market Size & Forecast
1.4.1 Global Oncology (Anti-cancer Drugs) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oncology (Anti-cancer Drugs) Sales in Volume (2017-2028)
1.4.3 Global Oncology (Anti-cancer Drugs) Price (2017-2028)
1.5 Global Oncology (Anti-cancer Drugs) Production Capacity Analysis
1.5.1 Global Oncology (Anti-cancer Drugs) Total Production Capacity (2017-2028)
1.5.2 Global Oncology (Anti-cancer Drugs) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology (Anti-cancer Drugs) Market Drivers
1.6.2 Oncology (Anti-cancer Drugs) Market Restraints
1.6.3 Oncology (Anti-cancer Drugs) Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology (Anti-cancer Drugs) Product and Services
2.1.4 Roche Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Oncology (Anti-cancer Drugs) Product and Services
2.2.4 Novartis Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Oncology (Anti-cancer Drugs) Product and Services
2.3.4 Celgene Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Oncology (Anti-cancer Drugs) Product and Services
2.4.4 Amgen Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Product and Services
2.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product and Services
2.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eli lilly & Co
2.7.1 Eli lilly & Co Details
2.7.2 Eli lilly & Co Major Business
2.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Product and Services
2.7.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Oncology (Anti-cancer Drugs) Product and Services
2.8.4 Pfizer Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Merck & Co.
2.9.1 Merck & Co. Details
2.9.2 Merck & Co. Major Business
2.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Product and Services
2.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Oncology (Anti-cancer Drugs) Product and Services
2.10.4 Sanofi Oncology (Anti-cancer Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oncology (Anti-cancer Drugs) Breakdown Data by Manufacturer
3.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oncology (Anti-cancer Drugs)
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology (Anti-cancer Drugs) Manufacturer Market Share in 2021
3.4.2 Top 6 Oncology (Anti-cancer Drugs) Manufacturer Market Share in 2021
3.5 Global Oncology (Anti-cancer Drugs) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oncology (Anti-cancer Drugs) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology (Anti-cancer Drugs) Market Size by Region
4.1.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Region (2017-2028)
4.1.2 Global Oncology (Anti-cancer Drugs) Revenue by Region (2017-2028)
4.2 North America Oncology (Anti-cancer Drugs) Revenue (2017-2028)
4.3 Europe Oncology (Anti-cancer Drugs) Revenue (2017-2028)
4.4 Asia-Pacific Oncology (Anti-cancer Drugs) Revenue (2017-2028)
4.5 South America Oncology (Anti-cancer Drugs) Revenue (2017-2028)
4.6 Middle East and Africa Oncology (Anti-cancer Drugs) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Type (2017-2028)
5.2 Global Oncology (Anti-cancer Drugs) Revenue by Type (2017-2028)
5.3 Global Oncology (Anti-cancer Drugs) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Application (2017-2028)
6.2 Global Oncology (Anti-cancer Drugs) Revenue by Application (2017-2028)
6.3 Global Oncology (Anti-cancer Drugs) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
7.2 North America Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
7.3 North America Oncology (Anti-cancer Drugs) Market Size by Country
7.3.1 North America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028)
7.3.2 North America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
8.2 Europe Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
8.3 Europe Oncology (Anti-cancer Drugs) Market Size by Country
8.3.1 Europe Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028)
8.3.2 Europe Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
9.2 Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
9.3 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Region
9.3.1 Asia-Pacific Oncology (Anti-cancer Drugs) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
10.2 South America Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
10.3 South America Oncology (Anti-cancer Drugs) Market Size by Country
10.3.1 South America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028)
10.3.2 South America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
11.2 Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
11.3 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Country
11.3.1 Middle East & Africa Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oncology (Anti-cancer Drugs) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oncology (Anti-cancer Drugs)
12.3 Oncology (Anti-cancer Drugs) Production Process
12.4 Oncology (Anti-cancer Drugs) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oncology (Anti-cancer Drugs) Typical Distributors
13.3 Oncology (Anti-cancer Drugs) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Oncology (Anti-cancer Drugs) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oncology (Anti-cancer Drugs) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Oncology (Anti-cancer Drugs) Product and Services
Table 6. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Oncology (Anti-cancer Drugs) Product and Services
Table 10. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Celgene Basic Information, Manufacturing Base and Competitors
Table 12. Celgene Major Business
Table 13. Celgene Oncology (Anti-cancer Drugs) Product and Services
Table 14. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Amgen Basic Information, Manufacturing Base and Competitors
Table 16. Amgen Major Business
Table 17. Amgen Oncology (Anti-cancer Drugs) Product and Services
Table 18. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Oncology (Anti-cancer Drugs) Product and Services
Table 22. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product and Services
Table 26. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eli lilly & Co Basic Information, Manufacturing Base and Competitors
Table 28. Eli lilly & Co Major Business
Table 29. Eli lilly & Co Oncology (Anti-cancer Drugs) Product and Services
Table 30. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Oncology (Anti-cancer Drugs) Product and Services
Table 34. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 36. Merck & Co. Major Business
Table 37. Merck & Co. Oncology (Anti-cancer Drugs) Product and Services
Table 38. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Sanofi Basic Information, Manufacturing Base and Competitors
Table 40. Sanofi Major Business
Table 41. Sanofi Oncology (Anti-cancer Drugs) Product and Services
Table 42. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Oncology (Anti-cancer Drugs) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 44. Global Oncology (Anti-cancer Drugs) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Oncology (Anti-cancer Drugs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Oncology (Anti-cancer Drugs) Production Capacity by Company, (K MT): 2020 VS 2021
Table 47. Head Office and Oncology (Anti-cancer Drugs) Production Site of Key Manufacturer
Table 48. Oncology (Anti-cancer Drugs) New Entrant and Capacity Expansion Plans
Table 49. Oncology (Anti-cancer Drugs) Mergers & Acquisitions in the Past Five Years
Table 50. Global Oncology (Anti-cancer Drugs) Sales by Region (2017-2022) & (K MT)
Table 51. Global Oncology (Anti-cancer Drugs) Sales by Region (2023-2028) & (K MT)
Table 52. Global Oncology (Anti-cancer Drugs) Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Oncology (Anti-cancer Drugs) Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 55. Global Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 56. Global Oncology (Anti-cancer Drugs) Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Oncology (Anti-cancer Drugs) Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Oncology (Anti-cancer Drugs) Price by Type (2017-2022) & (USD/MT)
Table 59. Global Oncology (Anti-cancer Drugs) Price by Type (2023-2028) & (USD/MT)
Table 60. Global Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 61. Global Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 62. Global Oncology (Anti-cancer Drugs) Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Oncology (Anti-cancer Drugs) Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Oncology (Anti-cancer Drugs) Price by Application (2017-2022) & (USD/MT)
Table 65. Global Oncology (Anti-cancer Drugs) Price by Application (2023-2028) & (USD/MT)
Table 66. North America Oncology (Anti-cancer Drugs) Sales by Country (2017-2022) & (K MT)
Table 67. North America Oncology (Anti-cancer Drugs) Sales by Country (2023-2028) & (K MT)
Table 68. North America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Oncology (Anti-cancer Drugs) Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 71. North America Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 72. North America Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 73. North America Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 74. Europe Oncology (Anti-cancer Drugs) Sales by Country (2017-2022) & (K MT)
Table 75. Europe Oncology (Anti-cancer Drugs) Sales by Country (2023-2028) & (K MT)
Table 76. Europe Oncology (Anti-cancer Drugs) Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Oncology (Anti-cancer Drugs) Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 79. Europe Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 80. Europe Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 81. Europe Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 82. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2017-2022) & (K MT)
Table 83. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2023-2028) & (K MT)
Table 84. Asia-Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 87. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 88. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 89. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 90. South America Oncology (Anti-cancer Drugs) Sales by Country (2017-2022) & (K MT)
Table 91. South America Oncology (Anti-cancer Drugs) Sales by Country (2023-2028) & (K MT)
Table 92. South America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Oncology (Anti-cancer Drugs) Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 95. South America Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 96. South America Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 97. South America Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 98. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Region (2017-2022) & (K MT)
Table 99. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Region (2023-2028) & (K MT)
Table 100. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 103. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 104. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 105. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 106. Oncology (Anti-cancer Drugs) Raw Material
Table 107. Key Manufacturers of Oncology (Anti-cancer Drugs) Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Oncology (Anti-cancer Drugs) Typical Distributors
Table 111. Oncology (Anti-cancer Drugs) Typical Customers
List of Figures
Figure 1. Oncology (Anti-cancer Drugs) Picture
Figure 2. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type in 2021
Figure 3. Blood Cancer
Figure 4. Breast Cancer
Figure 5. Gastrointestinal Cancer
Figure 6. Prostate Cancer
Figure 7. Others
Figure 8. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application in 2021
Figure 9. Chemotherapy
Figure 10. Targeted Therapy
Figure 11. Immunotherapy (Biologic Therapy)
Figure 12. Hormonal Therapy
Figure 13. Others
Figure 14. Global Oncology (Anti-cancer Drugs) Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 15. Global Oncology (Anti-cancer Drugs) Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Oncology (Anti-cancer Drugs) Sales (2017-2028) & (K MT)
Figure 17. Global Oncology (Anti-cancer Drugs) Price (2017-2028) & (USD/MT)
Figure 18. Global Oncology (Anti-cancer Drugs) Production Capacity (2017-2028) & (K MT)
Figure 19. Global Oncology (Anti-cancer Drugs) Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Oncology (Anti-cancer Drugs) Market Drivers
Figure 21. Oncology (Anti-cancer Drugs) Market Restraints
Figure 22. Oncology (Anti-cancer Drugs) Market Trends
Figure 23. Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturer in 2021
Figure 24. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturer in 2021
Figure 25. Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Oncology (Anti-cancer Drugs) Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Oncology (Anti-cancer Drugs) Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2017-2028)
Figure 29. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2017-2028)
Figure 30. North America Oncology (Anti-cancer Drugs) Revenue (2017-2028) & (USD Million)
Figure 31. Europe Oncology (Anti-cancer Drugs) Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Oncology (Anti-cancer Drugs) Revenue (2017-2028) & (USD Million)
Figure 33. South America Oncology (Anti-cancer Drugs) Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue (2017-2028) & (USD Million)
Figure 35. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
Figure 36. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2017-2028)
Figure 37. Global Oncology (Anti-cancer Drugs) Price by Type (2017-2028) & (USD/MT)
Figure 38. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 39. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2017-2028)
Figure 40. Global Oncology (Anti-cancer Drugs) Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
Figure 42. North America Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 43. North America Oncology (Anti-cancer Drugs) Sales Market Share by Country (2017-2028)
Figure 44. North America Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2017-2028)
Figure 45. United States Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
Figure 49. Europe Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 50. Europe Oncology (Anti-cancer Drugs) Sales Market Share by Country (2017-2028)
Figure 51. Europe Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2017-2028)
Figure 52. Germany Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2017-2028)
Figure 61. China Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
Figure 68. South America Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 69. South America Oncology (Anti-cancer Drugs) Sales Market Share by Country (2017-2028)
Figure 70. South America Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Oncology (Anti-cancer Drugs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Oncology (Anti-cancer Drugs) in 2021
Figure 82. Manufacturing Process Analysis of Oncology (Anti-cancer Drugs)
Figure 83. Oncology (Anti-cancer Drugs) Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
